Dr. Mehul Bhalja, MD (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Alexandria, LA with over 12 years of experience. What is your opinion of Dr. Mehul Bhalja, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 12 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mehul Bhalja, MD has received over $11,134 which includes payments from the following companies:
$4,715.85 from Medtronic Vascular, Inc.
$1,464.05 from Edwards Lifesciences Corporation
$1,378.19 from Abbott Laboratories
$548.00 from Terumo Medical Corporation
$318.87 from ABIOMED
$312.10 from Boston Scientific Corporation
$304.06 from Bard Peripheral Vascular, Inc.
$287.45 from AstraZeneca Pharmaceuticals LP
$246.62 from Pfizer Inc.
$212.32 from St. Jude Medical, Inc.
$210.71 from Amgen Inc.
$140.49 from Lantheus Medical Imaging, Inc.
$102.20 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$99.68 from Daiichi Sankyo Inc.
$98.46 from Cook Incorporated
$97.00 from Novartis Pharmaceuticals Corporation
$74.74 from United Therapeutics Corporation
$66.22 from Philips Electronics North America Corporation
$56.59 from sanofi-aventis U.S. LLC
$54.25 from Janssen Pharmaceuticals, Inc
Payments received by Dr. Mehul Bhalja, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!